FFAR2 and cancer: FFAR2 agonist, 4-CMTB, and FFAR4 agonist, GSK137647 significantly decreased both non-cancer (CCD 841 CoN) and cancer (SW-480) cell growth at the concentrations 10–200 μM as compared to untreated cells (Fig. 1a-b, S1a-b).